PET scans to guide radiation for limited metastatic prostate cancer
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial uses a special PET scan (POSLUMA) before and after radiation to see if it helps treat prostate cancer that has spread to a few spots outside the pelvis. It's for men whose cancer still responds to hormone therapy and who have not had widespread spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have prostate cancer that has not become resistant to hormone therapy (your testosterone is above 100).
- Your cancer has spread to 5 or fewer spots outside the pelvis (and not in the brain or liver).
- You are able to receive high-dose radiation to all those spots.
- You have not been on continuous hormone therapy for more than 3 months before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a radiation-focused approach for people with newly diagnosed (de novo) prostate cancer that has spread to a small number of spots, especially in bone. It aims to see how well the treatment controls the cancer while keeping side effects manageable.
This trial tests whether doing a second PET scan during treatment can help doctors decide if more precise radiation (SABR) should be used on all cancer spots in men with prostate cancer that has spread. It aims to see if this approach can better control the cancer while reducing side effects.
This trial tests whether adding radiation to the prostate and to any remaining cancer spots can help when hormone therapy alone hasn't fully controlled the cancer. It is for men whose PSA remains slightly elevated after six months of initial hormone treatment.
This trial is testing whether giving radiation to all spots of cancer that show up on a PSMA PET scan works better than giving radiation only to the main tumor in the prostate. It is for men whose prostate cancer has spread to a few other places (up to 10 spots).
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This trial tests whether a special PET scan (called PSMA, which pictures prostate cancer cells) can help doctors better find any remaining or spread of prostate cancer when your PSA level is rising again. It's for people who are planning radiation therapy, and the goal is to see if the scan changes the treatment plan.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.